Americhem establishes medical insurance division
Americhem announced that it will create a separate "Americhem Healthcare Division". The newly formed Healthcare Division will focus on optimizing product performance and delivering innovative solutions. The company will work closely with medical OEMs to provide one-stop technical and service support.
According to Americhem, the newly formed Healthcare Division will support customers every step of the way through its global expertise in material selection, medical device product development and cross-team collaboration. Bill Feldman, global commercial director of Americhem's Healthcare Business Unit, said that the business unit's developers and sales teams focused on medical applications are located in many countries and regions in North America, Europe and Asia, enabling rapid project development and small batch production. At the same time, it supports customers' global regulatory needs and provides precise and professional medical field knowledge. He said the division will focus on building and expanding its Pennsylvania plant to demonstrate its commitment to the healthcare industry with a comprehensive clean manufacturing facility. At the same time, the division also has other factories that have passed ISO13485 certification to provide services to customers.
2026-09-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pritzker Private Capital Acquires Majority Stake in Americhem
-
China's National Health Insurance Bureau is studying the inclusion of innovative medical supplies into medical insurance
-
ExxonMobil Eyes $1 Billion Petrochemical Asset Sale in Europe Amid Industry Downturn
-
Nitrogen’s Quiet Powerhouse: CF Industries Delivers Record Profit Amid Global Food Security Shift
-
From Recovery to Roaring: Mosaic’s Q3 2025 Delivers Triple-Digit Profit Surge on Fertilizer Resurgence
-
“Falling Revenue, Soaring Profits”: Is AkzoNobel’s Financial Alchemy Real Muscle—or Just Smoke and Mirrors?
-
Iran Fully Halts Petrochemical Exports as the Middle East Supply System Faces Restructuring
-
Lenzing Group, a European fiber giant with over a century of history, is being forced to close two plants and cut 2,000 jobs globally
-
Evonik Supervisory Board Approves Executive Changes, Extends Kullmann’s Term to 2030
-
Givaudan to Build New Fragrance Compounding Facility in Pedro Escobedo, Mexico
Recommend Reading
-
Ineos Exits Sinopec Tianjin Joint Venture, Pays $120 Million "Breakup Fee"
-
Dow Chemical to Close Three European Plants, Cut 800 Jobs
-
Evonik Reports Strong Q2 Results as Supply Chain Disruptions Boost Chemical Margins
-
Another Strategic Move! DuPont Launches a New Specialty Lubricants Project in Zhangjiagang
-
Eurofragance Opens New Creative Center in Jakarta to Expand Its Asian Footprint
-
This Week's Aniline Market Shows High Prices (8.31-9.4) in China
-
Business Society’s Urea Market Outlook on September 4, 2026: Volatile
-
Cost Support: Activated Carbon Prices Rise
-
Business Society’s Market Outlook for n-Butanol on September 4, 2026: Fluctuating Trend
-
Business Society’s Market Outlook for Acrylic Acid on September 4, 2026: Fluctuating Trend